Download presentation
Presentation is loading. Please wait.
Published byValéria Mészárosné Modified over 5 years ago
1
Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo Barjesh Chander Sharma, Praveen Sharma, Amit Agrawal, Shiv Kumar Sarin Gastroenterology Volume 137, Issue 3, Pages e1 (September 2009) DOI: /j.gastro Copyright © 2009 AGA Institute Terms and Conditions
2
Figure 1 Probability of developing HE in patients receiving lactulose (dotted line) or placebo (continuous line). Figures in parentheses indicate the cumulative number of subjects who developed HE. Gastroenterology , e1DOI: ( /j.gastro ) Copyright © 2009 AGA Institute Terms and Conditions
3
Supplementary Figure 1 Flow of participants in the study.
Gastroenterology , e1DOI: ( /j.gastro ) Copyright © 2009 AGA Institute Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.